Author(s): Mayur S. Jain, Shashikant D. Barhate, Rahul D. Shimpi

Email(s): mayurjain176@gmail.com

DOI: 10.52711/2231-5691.2022.00029   

Address: Mayur S. Jain*, Shashikant D. Barhate, Rahul D. Shimpi
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, Jamner, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 12,      Issue - 2,     Year - 2022


ABSTRACT:
Mobocertinib is a kinase inhibitor targeted against human epidermal growth factor receptor (EGFR). It is used particularly in the action of non-small cell lung cancer (NSCLC) caused by exon 20 placing mutations in the EGFR gene, which are classically linked through a poorer prognosis (as compared to "classical" EGFR mutants causing NSCLC) and are linked with opposition to standard targeted EGFR inhibitors. Mobocertinib appears to be an effective means of treating this otherwise treatment-resistant NSCLC, exerting an inhibitory effect on EGFR exon 20 insertion mutant variants at concentrations 1.5- to 10-fold lower than those required to inhibit wild-type EGFR.2 Mobocertinib, below the brand name Exkivity (Takeda Pharmaceuticals Inc.), was granted accelerated agreement by the FDA in September 2021 for the action of locally advanced or metastatic NSCLC in patients with EGFR exon 20 insertion mutations who have failed previous therapies.1


Cite this article:
Mayur S. Jain, Shashikant D. Barhate, Rahul D. Shimpi. Mobocertinib is an Oral kinase inhibitor targeted against EGFR and used in the treatment of Non-small cell Lung cancer: A Review. Asian Journal of Pharmaceutical Research. 2022; 12(2):179-2. doi: 10.52711/2231-5691.2022.00029

Cite(Electronic):
Mayur S. Jain, Shashikant D. Barhate, Rahul D. Shimpi. Mobocertinib is an Oral kinase inhibitor targeted against EGFR and used in the treatment of Non-small cell Lung cancer: A Review. Asian Journal of Pharmaceutical Research. 2022; 12(2):179-2. doi: 10.52711/2231-5691.2022.00029   Available on: https://asianjpr.com/AbstractView.aspx?PID=2022-12-2-12


REFERENCES:
1.    www.drug bank.com
2.    FDA Approved Drug Products: Exkivity (mobocertinib) capsules for oral use
3.    Bethune G, Bethune D, Ridgway N, Xu Z: Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J Thorac Dis. 2010; 2(1): 48-51.
4.    Vyse S, Huang PH: Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. Signal Transduct Target Ther. 2019; 4: 5. doi: 10.1038/s41392-019-0038-9. eCollection 2019
5.    Zhang S, Jin S, Griffin C, Feng Z, Lin J, Baratta M, Brake R, Venkatakrishnan K, Gupta N: Single-Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK-788) in Healthy Volunteers: Low-Fat Meal Effect and Relative Bioavailability of 2 Capsule Products. Clin Pharmacol Drug Dev. 2021 Sep; 10(9): 1028-1043. doi: 10.1002/cpdd.951. Epub 2021 Jun 12.
6.    FDA grants accelerated approval to mobocertinib for metastatic non-sma". U.S. Food and Drug Administration (FDA). 16 September 2021. Retrieved 16 September 2021.   This article incorporates text from this source, which is in the public domain.
7.    "What Is Non-Small Cell Lung Cancer?". www.cancer.org.
8.    "Non-small cell lung cancer treatment – National Cancer Institute". 1 January 1980. Retrieved 19 October 2008.
9.    Non-small cell lung cancer". University of Maryland Medical Center. Retrieved 4 December 2017.
10.    Liu X, Conner H, Kobayashi T, Kim H, Wen F, Abe S, et al. (August 2005). "Cigarette smoke extract induces DNA damage but not apoptosis in human bronchial epithelial cells". American Journal of Respiratory Cell and Molecular Biology. 33 (2): 121–9.

Recomonded Articles:

Author(s): Rutuja S. Shah, Rutuja R. Shah, Manoj M. Nitalikar, Chandrakant S. Magdum

DOI: 10.5958/2231-5691.2017.00028.4         Access: Open Access Read More

Author(s): Ravi Kumar, Komal

DOI: 10.5958/2231-5691.2021.00003.4         Access: Open Access Read More

Author(s): Rutuja S. Shah, Rutuja R. Shah, Manoj M. Nitalikar, Chandrakant S. Magdum

DOI: 10.5958/2231-5691.2017.00024.7         Access: Open Access Read More

Author(s): Injamamul Haque, Ravikumar, Narayanaswamy VB, Mohibul Hoque

DOI: 10.5958/2231-5691.2016.00023.X         Access: Open Access Read More

Author(s): Dilip M. Kumbhar, Vijay D. Havaldar, Kailas K. Mali, Remeth J. Dias, Vishwajeet S. Ghorpade, Rahul B. Londhe

DOI: 10.5958/2231-5691.2017.00002.8         Access: Open Access Read More

Author(s): Gawai Mamata N., Aher Smita S, Saudager Ravindra B.

DOI:         Access: Open Access Read More

Author(s): Jude Chigozie Ikewuchi, Catherine Chidinma Ikewuchi and Mercy Onuekwuzu Ifeanacho

DOI:         Access: Open Access Read More

Author(s): P. S. Patil, S. R. Kumbhoje, S.S. Patil

DOI: 10.5958/2231-5691.2015.00018.0         Access: Open Access Read More

Author(s): Mamatha Kola, Subharna Mallik, Pranusha Palle, Pallavi Kamarapu

DOI:         Access: Open Access Read More

Author(s): Valli G, Jeyalakshmi M.

DOI:         Access: Open Access Read More

Author(s): Uma Sankar Gorla,. M. Savithri, G.S.N. Koteswara Rao,. Y. Niharika, . P. Devi Sree Sathya, . V. Harika

DOI: 10.5958/2231-5691.2018.00006.0         Access: Open Access Read More

Author(s): Venkateswarlu G*1,Manoranjan S1, Sharada N1, Sravan Prasad M2, Azeez MD1, Rajeshwari.E

DOI:         Access: Open Access Read More

Author(s): Shiv Kumar Gupta, Anuradha Singh, Babita Kumar, Bharti Sharma

DOI: 10.5958/2231-5691.2017.00012.0         Access: Open Access Read More

Author(s): Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad

DOI: 10.5958/2231-5691.2018.00041.2         Access: Open Access Read More

Author(s): Ikewuchi Jude C.1*, Ikewuchi Catherine C.1, Ifeanacho Mercy O.1, Igboh Ngozi M.2, Enuneku Emeke C.1 and Osayande Osazee I.1

DOI:         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags